Cytogen, Inc. (KOSDAQ:217330)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,055.00
-35.00 (-1.13%)
At close: Sep 11, 2026

Cytogen Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
14,89310,99131,20154,83815,87830,288
Short-Term Investments
7,52520,52210,06549.4650.435,515
Trading Asset Securities
----1,993-
Cash & Short-Term Investments
22,41831,51341,26654,88717,92235,803
Cash Growth
-36.18%-23.64%-24.82%206.26%-49.94%-
Accounts Receivable
6,4786,0813,700473.96588.2388.9
Other Receivables
421.99566.58836.34259.88164.15137.48
Receivables
6,9006,6474,536733.84752.38226.38
Inventory
3,9844,3891,72325.3131.47-
Prepaid Expenses
261.88155.94184.8234.71186.7373.13
Other Current Assets
181.75522.66368.71122.29396.767,487
Total Current Assets
33,74543,22848,07956,00319,38943,589
Property, Plant & Equipment
7,8336,3766,8284,9803,1042,808
Long-Term Investments
1,5571,5572,4895,5277,3317,321
Goodwill
4,8204,8254,8252,7235,712-
Other Intangible Assets
4,9045,0558,6244,8305,3101,496
Long-Term Deferred Tax Assets
670.2691.24884.61---
Other Long-Term Assets
1,222507.32748.49386.96375.1313.75
Total Assets
54,75162,24072,47874,45041,22055,528

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,8013,4571,666206.64189.2112.63
Accrued Expenses
751.13614.95843.76730.431,006376.4
Short-Term Debt
104,771327.927,98025,7583,280
Current Portion of Leases
517.8428.71917556.4474.98442.66
Other Current Liabilities
1,4245,477960.51,2746,5022,579
Total Current Liabilities
4,50414,7494,71510,74733,9306,791
Long-Term Debt
13,10610,71513,2778,371-20,445
Long-Term Leases
631.83364.73349.93669.13191.3456.46
Pension & Post-Retirement Benefits
71.36139.93235.5937.0552.62191.07
Long-Term Deferred Tax Liabilities
---549.23838.98-
Other Long-Term Liabilities
2,691279.034,958721.58551.384,635
Total Liabilities
21,00326,24723,53521,09535,56432,519

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
11,56511,56511,56511,1398,9342,947
Additional Paid-In Capital
119,059117,434118,236107,52350,75954,635
Retained Earnings
-101,001-97,532-85,189-68,072-52,302-33,531
Treasury Stock
-3,234-3,234-3,234-3,234-3,234-3,234
Comprehensive Income & Other
7,0087,3297,2055,9981,5002,192
Total Common Equity
33,39735,56248,58353,3555,65623,009
Minority Interest
351.25430.51359.78---
Shareholders' Equity
33,74835,99348,94353,3555,65623,009
Total Liabilities & Equity
54,75162,24072,47874,45041,22055,528

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
14,26516,27914,87217,57626,42424,624
Net Cash (Debt)
8,15215,23326,39537,311-8,50211,179
Net Cash Growth
-58.66%-42.29%-29.26%---
Net Cash Per Share
352.94660.311168.282040.21-481.37659.73
Filing Date Shares Outstanding
23.1323.1323.0722.2217.8117.5
Total Common Shares Outstanding
23.1323.1323.0722.2217.8117.5
Working Capital
29,24228,47943,36445,256-14,54136,798
Book Value Per Share
1444.071537.712105.942401.36317.611314.64
Tangible Book Value
23,67325,68235,13345,803-5,36521,513
Tangible Book Value Per Share
1023.631110.461522.942061.45-301.261229.19
Land
308.3286.98294257.88--
Buildings
2,3582,1952,2491,973--
Machinery
4,4954,6442,080852.03969.67432.63
Construction In Progress
253.71-26.41465.06507.95